Waning of first- and second-dose chadox1 and bnt162b2 covid-19 vaccinations: a pooled target trial study of 12.9 million individuals in england, northern ireland, scotland and wales

HIGHLIGHTS

• who: Key Messages and collaborators from the Centre for Medical Informatics, Usher Institute, The University of Edinburgh, Edinburgh, UK have published the Article: Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales, in the Journal: (JOURNAL) of 30/06/2021
• what: The aim of this study was to investigate waning in VE/relative VE (rVE) against severe COVID-19 outcomes using pooled data from across the four nations of the UK using a target trial . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.